Real-World Effectiveness of rFIXFc Prophylaxis in Patients with Haemophilia B Switched from Standard Half-Life Therapy in Three European Countries.
Eva FundingGillian LoweLone H PoulsenSusan ShapiroJohannes OldenburgDaniel ErikssonAletta FalkCarly RichPublished in: Advances in therapy (2023)
This study demonstrates the effectiveness of rFIXFc prophylaxis in real-world clinical practice. Improvements in both clinical effectiveness and factor usage associated with rFIXFc prophylaxis may potentially reduce patient burden and improve quality of life.